Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

BAY 59-8862 in Treating Patients With Advanced Kidney Cancer

ClinicalTrials.gov ID: NCT00039169

Public ClinicalTrials.gov record NCT00039169. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 3, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Uncontrolled Phase II Multi-Center Trial Evaluating Anti-Tumor Efficacy and Safety of BAY 59-8862 in Patients With Advanced Renal Cell Cancer

Study identification

NCT ID
NCT00039169
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Theradex
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

  • ortataxel Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2001
Primary completion
Not listed
Completion
Not listed
Last update posted
Jul 23, 2008

Started 2001

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Scripps Clinic La Jolla California 92037
Medical Consultants Muncie Indiana 47303
Ochsner Clinic New Orleans Louisiana 70121
Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201
206 Research Associates Greenbelt Maryland 20770
St. Louis University Health Sciences Center St Louis Missouri 63110-0250
Billings Oncology Associates Billings Montana 59101
Cancer Institute of New Jersey New Brunswick New Jersey 08903
State University of New York - Upstate Medical University Syracuse New York 13210
Huntsman Cancer Institute Salt Lake City Utah 84112
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00039169, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2008 · Synced May 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00039169 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →